# Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 4] I.V. Infusion 100mg "CTNK" (ベバシズマブＢＳ点滴静注１００ｍｇ「ＣＴＮＫ」)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291463A1020). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291463A1020
- **Product name (Japanese):** ベバシズマブＢＳ点滴静注１００ｍｇ「ＣＴＮＫ」
- **Product name (English):** Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 4] I.V. Infusion 100mg "CTNK"
- **Active ingredient:** ベバシズマブ（遺伝子組換え）［ベバシズマブ後続４］
- **Active ingredient (INN):** Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 4]
- **Strength / unit:** １００ｍｇ４ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Nippon Kayaku (日本化薬)
- **Brand / generic:** Generic (後発医薬品)
- **NHI price (reference only):** JPY 6038 per １００ｍｇ４ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291463A1020
- **JSON:** https://www.nifujipharma.com/api/drugs/4291463A1020

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Bevacizumab%20(Genetical%20Recombination)%20%5BBevacizumab%20Biosimilar%204%5D%20I.V.%20Infusion%20100mg%20%22CTNK%22%20(%E3%83%99%E3%83%90%E3%82%B7%E3%82%BA%E3%83%9E%E3%83%96%EF%BC%A2%EF%BC%B3%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%91%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87%E3%80%8C%EF%BC%A3%EF%BC%B4%EF%BC%AE%EF%BC%AB%E3%80%8D)%20%2F%20YJ%204291463A1020#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 4]

- [Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 4] I.V. Infusion 400mg "CTNK" (ベバシズマブＢＳ点滴静注４００ｍｇ「ＣＴＮＫ」)](https://www.nifujipharma.com/drugs/4291463A2027) — ４００ｍｇ１６ｍＬ１瓶, Nippon Kayaku, generic